Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jacques Cadranel

Showing results (161-170 of 329) with videos related to

Pageof 33
Sort By:
Respiratory Medicine|May 1, 2012
Diffuse alveolar hemorrhage in immunocompetent patients: etiologies and prognosis revisitedNicolas de Prost, Antoine Parrot, Elise Cuquemelle, et al.
Lung Cancer (Amsterdam, Netherlands)|May 3, 2016
EGFR and KRAS mutation status in non-small-cell lung cancer occurring in HIV-infected patientsPerrine Créquit, Anne-Marie Ruppert, Nathalie Rozensztajn, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|July 23, 2015
Crizotinib Associated with Ground-Glass Opacity Predominant Pattern Interstitial Lung Disease: A Retrospective Observational Cohort Study with a Systematic Literature ReviewPerrine Créquit, Marie Wislez, Jocelyne Fleury Feith, et al.
Bulletin Du Cancer|October 10, 2014
[ALK-rearranged non-small cell lung cancer: how to optimize treatment with crizotinib in routine practice?]Clarisse Audigier-Valette, Nicolas Girard, Alexis B Cortot, et al.
Expert Review of Anticancer Therapy|November 22, 2014
ALK-rearranged non-small cell lung cancers: how best to optimize the safety of crizotinib in clinical practice?Nicolas Girard, Clarisse Audigier-Valette, Alexis B Cortot, et al.
The Clinical Respiratory Journal|January 11, 2014
Characteristics and outcomes of chronic pulmonary aspergillosis: a retrospective analysis of a tertiary hospital registryBoubou Camara, Emilie Reymond, Christel Saint-Raymond, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|September 6, 2011
Skin toxicities compromise prolonged pemetrexed treatmentBelen Eguia, Anne-Marie Ruppert, Julie Fillon, et al.
Cancer Medicine|January 11, 2014
Factors associated with early progression of non-small-cell lung cancer treated by epidermal growth factor receptor tyrosine-kinase inhibitorsNathalie Rozensztajn, Anne-Marie Ruppert, Armelle Lavole, et al.
Blood|November 15, 2007
Multicentric Castleman disease is associated with polyfunctional effector memory HHV-8-specific CD8+ T cellsAmélie Guihot, Eric Oksenhendler, Lionel Galicier, et al.
European Journal of Cancer (Oxford, England : 1990)|July 17, 2022
Influence of the SARS-CoV-2 outbreak on management and prognosis of new lung cancer cases, a retrospective multicentre real-life cohort studySonia Priou, Guillaume Lamé, Gérard Zalcman, et al.
Pageof 33

Showing results (161-170 of 329) with videos related to

Sort By:
Pageof 33
Respiratory Medicine|May 1, 2012
Diffuse alveolar hemorrhage in immunocompetent patients: etiologies and prognosis revisitedNicolas de Prost, Antoine Parrot, Elise Cuquemelle, et al.
Lung Cancer (Amsterdam, Netherlands)|May 3, 2016
EGFR and KRAS mutation status in non-small-cell lung cancer occurring in HIV-infected patientsPerrine Créquit, Anne-Marie Ruppert, Nathalie Rozensztajn, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|July 23, 2015
Crizotinib Associated with Ground-Glass Opacity Predominant Pattern Interstitial Lung Disease: A Retrospective Observational Cohort Study with a Systematic Literature ReviewPerrine Créquit, Marie Wislez, Jocelyne Fleury Feith, et al.
Bulletin Du Cancer|October 10, 2014
[ALK-rearranged non-small cell lung cancer: how to optimize treatment with crizotinib in routine practice?]Clarisse Audigier-Valette, Nicolas Girard, Alexis B Cortot, et al.
Expert Review of Anticancer Therapy|November 22, 2014
ALK-rearranged non-small cell lung cancers: how best to optimize the safety of crizotinib in clinical practice?Nicolas Girard, Clarisse Audigier-Valette, Alexis B Cortot, et al.
The Clinical Respiratory Journal|January 11, 2014
Characteristics and outcomes of chronic pulmonary aspergillosis: a retrospective analysis of a tertiary hospital registryBoubou Camara, Emilie Reymond, Christel Saint-Raymond, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|September 6, 2011
Skin toxicities compromise prolonged pemetrexed treatmentBelen Eguia, Anne-Marie Ruppert, Julie Fillon, et al.
Cancer Medicine|January 11, 2014
Factors associated with early progression of non-small-cell lung cancer treated by epidermal growth factor receptor tyrosine-kinase inhibitorsNathalie Rozensztajn, Anne-Marie Ruppert, Armelle Lavole, et al.
Blood|November 15, 2007
Multicentric Castleman disease is associated with polyfunctional effector memory HHV-8-specific CD8+ T cellsAmélie Guihot, Eric Oksenhendler, Lionel Galicier, et al.
European Journal of Cancer (Oxford, England : 1990)|July 17, 2022
Influence of the SARS-CoV-2 outbreak on management and prognosis of new lung cancer cases, a retrospective multicentre real-life cohort studySonia Priou, Guillaume Lamé, Gérard Zalcman, et al.
Pageof 33